The serine/threonine kinase Akt/PKB plays key roles in the regulation of cell growth, survival, and metabolism. It remains unclear, however, whether the functions of individual Akt/PKB isoforms are distinct. To investigate the function of Akt2/PKBβ, mice lacking this isoform were generated. Both male and female Akt2/PKBβ-null mice exhibit mild growth deficiency and an age-dependent loss of adipose tissue or lipoatrophy, with all observed adipose depots dramatically reduced by 22 weeks of age. Akt2/PKBβ-deficient mice are insulin resistant with elevated plasma triglycerides. In addition, Akt2/PKBβ-deficient mice exhibit fed and fasting hyperglycemia, hyperinsulinemia, glucose intolerance, and impaired muscle glucose uptake. In males, insulin resistance progresses to a severe form of diabetes accompanied by pancreatic β cell failure. In contrast, female Akt2/PKBβ-deficient mice remain mildly hyperglycemic and hyperinsulinemic until at least one year of age. Thus, Akt2/PKBβ-deficient mice exhibit growth deficiency similar to that reported previously for mice lacking Akt1/PKBα, indicating that both Akt2/PKBβ and Akt1/PKBα participate in the regulation of growth. The marked hyperglycemia and loss of pancreatic β cells and adipose tissue in Akt2/PKBβ-deficient mice suggest that Akt2/PKBβ plays critical roles in glucose metabolism and the development or maintenance of proper adipose tissue and islet mass for which other Akt/PKB isoforms are unable to fully compensate.
Robert S. Garofalo, Stephen J. Orena, Kristina Rafidi, Anthony J. Torchia, Jeffrey L. Stock, Audrey L. Hildebrandt, Timothy Coskran, Shawn C. Black, Dominique J. Brees, Joan R. Wicks, John D. McNeish, Kevin G. Coleman
Title and authors | Publication | Year |
---|---|---|
Skeletal Muscle Insulin Resistance in a Novel Fetal Growth Restriction Model
Tokita K, Shoji H, Arai Y, Awata K, Santosa I, Murano Y, Shimizu T |
Pediatric reports | 2023 |
The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers
Di Pietro P, Izzo C, Abate AC, Iesu P, Rusciano MR, Venturini E, Visco V, Sommella E, Ciccarelli M, Carrizzo A, Vecchione C |
Biomolecules | 2023 |
Interfering with the Ubiquitin-Mediated Regulation of Akt as a Strategy for Cancer Treatment
Paccosi E, Balzerano A, Proietti-De-Santis L |
International journal of molecular sciences | 2023 |
Hypolipidemic Effects of Beetroot Juice in SHR-CRP and HHTg Rat Models of Metabolic Syndrome: Analysis of Hepatic Proteome.
Šilhavý J, Mlejnek P, Šimáková M, Malínská H, Marková I, Hüttl M, Miklánková D, Kazdová L, Vrbacký M, Pecinová A, Mráček T, Pravenec M |
Metabolites | 2023 |
Design, synthesis, and evaluation of benzofuran-based chromenochalcones for antihyperglycemic and antidyslipidemic activities
Korthikunta V, Singh R, Srivastava R, Pandey J, Srivastava A, Chaturvedi U, Mishra A, Srivastava AK, Tamrakar AK, Tadigoppula N |
2023 | |
Investigation of the inhibitory behavior of XFE and mitoxantrone molecules in interaction with AKT1 protein: a molecular dynamics simulation study.
Amiran MR, Taghdir M, Abasi Joozdani F |
Journal of Molecular Modeling | 2023 |
Monitoring AKT activity and targeting in live tissue and disease contexts using a real-time Akt-FRET biosensor mouse.
Conway JRW, Warren SC, Lee YK, McCulloch AT, Magenau A, Lee V, Metcalf XL, Stoehr J, Haigh K, Abdulkhalek L, Guaman CS, Reed DA, Murphy KJ, Pereira BA, Mélénec P, Chambers C, Latham SL, Lenthall H, Deenick EK, Ma Y, Phan T, Lim E, Joshua AM, Walters S, Grey ST, Shi YC, Zhang L, Herzog H, Croucher DR, Philp A, Scheele CLGJ, Herrmann D, Sansom OJ, Morton JP, Papa A, Haigh JJ, Nobis M, Timpson P |
Science Advances | 2023 |
DNAJB3 attenuates ER stress through direct interaction with AKT.
Islam Z, Diane A, Khattab N, Dehbi M, Thornalley P, Kolatkar PR |
PloS one | 2023 |
Actuation of single downstream nodes in growth factor network steers immune cell migration
Pal DS, Banerjee T, Lin Y, de Trogoff F, Borleis J, Iglesias PA, Devreotes PN |
Developmental Cell | 2023 |